Candriam SCA’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-198,043
| Closed | -$685K | – | 881 |
|
|
2022
Q3 | $685K | Sell |
198,043
-319,549
| -62% | -$1.22M | ﹤0.01% | 781 |
|
|
2022
Q2 | $1.53M | Hold |
517,592
| – | – | 0.01% | 556 |
|
|
2022
Q1 | $4.56M | Sell |
517,592
-30,137
| -6% | -$333K | 0.03% | 366 |
|
|
2021
Q4 | $8.79M | Sell |
547,729
-60,794
| -10% | -$1.14M | 0.06% | 283 |
|
|
2021
Q3 | $12.7M | Hold |
608,523
| – | – | 0.09% | 234 |
|
|
2021
Q2 | $16.3M | Sell |
608,523
-67,607
| -10% | -$1.98M | 0.11% | 215 |
|
|
2021
Q1 | $14.8M | Buy |
676,130
+5
| +0% | +$121 | 0.12% | 184 |
|
|
2020
Q4 | $15.5M | Buy |
676,125
+94,271
| +16% | +$2.17M | 0.12% | 186 |
|
|
2020
Q3 | $14.7M | Buy |
581,854
+113,421
| +24% | +$3.1M | 0.14% | 176 |
|
|
2020
Q2 | $13.1M | Sell |
468,433
-279,330
| -37% | -$4.85M | 0.14% | 172 |
|
|
2020
Q1 | $7.95M | Hold |
747,763
| – | – | 0.09% | 258 |
|
|
2019
Q4 | $8.14M | Sell |
747,763
-7,225
| -1% | -$71.5K | 0.09% | 262 |
|
|
2019
Q3 | $9.63M | Buy |
754,988
+4,000
| +0.5% | +$57.6K | 0.13% | 191 |
|
|
2019
Q2 | $12.7M | Buy |
750,988
+85,500
| +13% | +$1.47M | 0.16% | 152 |
|
|
2019
Q1 | $12M | Buy |
665,488
+122,501
| +23% | +$2.12M | 0.15% | 156 |
|
|
2018
Q4 | $6.9M | Buy |
542,987
+186,387
| +52% | +$3.13M | 0.11% | 222 |
|
|
2018
Q3 | $7.65M | Buy |
356,600
+265,000
| +289% | +$5.65M | 0.1% | 233 |
|
|
2018
Q2 | $1.89M | Buy |
91,600
+16,600
| +22% | +$374K | 0.03% | 499 |
|
|
2018
Q1 | $1.89M | Hold |
75,000
| – | – | 0.03% | 491 |
|
|
2017
Q4 | $1.43M | Buy |
+75,000
| New | +$1.4M | 0.02% | 517 |
|
|
2017
Q1 | – | Sell |
-60,000
| Closed | -$1.23M | – | 703 |
|
|
2016
Q4 | $1.23M | Sell |
60,000
-50,000
| -45% | -$1.26M | 0.03% | 479 |
|
|
2016
Q3 | $3.29M | Sell |
110,000
-39,500
| -26% | -$1.17M | 0.08% | 269 |
|
|
2016
Q2 | $4.04M | Buy |
149,500
+31,500
| +27% | +$710K | 0.1% | 215 |
|
|
2016
Q1 | $2.2M | Sell |
118,000
-17,100
| -13% | -$326K | 0.06% | 307 |
|
|
2015
Q4 | $4.18M | Buy |
135,100
+29,000
| +27% | +$881K | 0.11% | 199 |
|
|
2015
Q3 | $2.27M | Sell |
106,100
-27,900
| -21% | -$875K | 0.06% | 319 |
|
|
2015
Q2 | $5.09M | Sell |
134,000
-91,000
| -40% | -$2.99M | 0.11% | 238 |
|
|
2015
Q1 | $7.06M | Hold |
225,000
| – | – | 0.14% | 192 |
|
|
2014
Q4 | $7.89M | Buy |
+225,000
| New | +$5.61M | 0.17% | 177 |
|
Other funds holding MGNX
BG
AC
WA
Candriam SCA's MGNX Position: Q4 2022 in Review
Candriam SCA sold out of MacroGenics (MGNX) in Q4 2022, closing a stake of 198,043 shares — an estimated $685K sold.
Candriam SCA first reported a position in MGNX in Q4 2014 and held it in 29 quarters. The position peaked at $16.3M in Q2 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q4 2022.
- Candriam SCA reported no remaining MacroGenics position as of Q4 2022 after selling out during the quarter.
- Candriam SCA sold 198,043 MacroGenics shares in Q4 2022, an estimated $685K.
- Candriam SCA first reported a position in MacroGenics in Q4 2014 and held it in 29 quarters.
- Candriam SCA's MacroGenics position peaked at $16.3M in Q2 2021.
- 135 funds tracked by Wall St. Rank held MacroGenics as of Q4 2022.
Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.